|
Re: Am I the only one thinking that..
Irvine nothing is safe there are many people dying of the side effect of chemo everyday. We all know here that we have to accept collateral damages in order to LIVE. Trials could be run as phase 1.
All of us end up not fitting any criteria because we have had too many lines of chemo and targetted drugs.
The real problem is the unwillingness of pharmas to work together (yes because of profit), yes I agree with you all about that.
Every researchers agrees onthe need to block various pathways so. My question is still: How can we force them to work together on creative blocking and personalised(ish) trials. Like they did for HIV research, how did they do it???
__________________
35 y/o
June 06: BC stage I
Grade 3; ER/PR neg
Her-2+++; lumpectomies
Aug 06: Stage IV
liver mets: 6 tumours
July 06 to Jan 07: 2*FEC+6*Taxotere; 3*TACE; LITT
March 07- Sept 07: Vaccination trial (phase 2, peptide based) at the UW (Seattle).
Herceptin since 2006
NED til Oct 09
Recurrence Oct 2009: to internal mammary gland since October 2009 missed on Oct and March 2010 scan.. palpable nodes in May 2010 when I realised..
Nov 2011:7 mets to lungs progressing fast failed hercp/tykerb/xeloda combo..
superior vena cava blocked: stent but face remains puffy
April 2012: Teresa Trial, randomised to TDM1
Nov 2012 progressing on TDM1
Dec 2012 blockage of my airways by tumours, obliteration of these blocking tumours breathing better but hoping for more- at mo too many tumours to count in the lungs and nodes.
Dec 2012 Starting new trial S-222611 phase 1b dual egfr her2+ inhibitor.
'Under no circumstances should you lose hope..' Dalai Lama
|